Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
US Stock MarketDetailed Quotes
AKBA Akebia Therapeutics
- 2.450
- -0.030-1.21%
Close May 14 16:00 ET
- 2.450
- +0.000+0.00%
Pre 08:37 ET
643.46MMarket Cap-11.67P/E (TTM)
2.540High2.425Low3.66MVolume2.480Open2.480Pre Close9.11MTurnover1.43%Turnover RatioLossP/E (Static)262.64MShares2.90052wk High26.06P/B629.38MFloat Cap0.80052wk Low--Dividend TTM256.89MShs Float31.000Historical High--Div YieldTTM4.64%Amplitude0.241Historical Low2.486Avg Price1Lot Size
Akebia Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 170.19%113.37M | 20.84%51.87M | 20.84%51.87M | -26.89%34.02M | -26.27%39.5M | -26.32%41.96M | -52.55%42.93M | -52.55%42.93M | -67.86%46.53M | -62.77%53.57M |
| -Cash and cash equivalents | 170.19%113.37M | 20.84%51.87M | 20.84%51.87M | -26.89%34.02M | -26.27%39.5M | -26.32%41.96M | -52.55%42.93M | -52.55%42.93M | -67.86%46.53M | -62.77%53.57M |
| Receivables | 131.17%61.54M | -12.53%34.37M | -12.53%34.37M | 42.40%32.17M | 52.08%29.77M | 49.71%26.62M | -2.47%39.29M | -2.47%39.29M | -2.17%22.59M | -76.09%19.57M |
| -Accounts receivable | 131.17%61.54M | -12.53%34.37M | -12.53%34.37M | 42.40%32.17M | 52.08%29.77M | 49.71%26.62M | -2.47%39.29M | -2.47%39.29M | -2.17%22.59M | -76.09%19.57M |
| Inventory | -22.72%19.73M | 3.52%16.24M | 3.52%16.24M | 11.12%20.49M | 14.19%23.87M | 23.92%25.53M | -27.25%15.69M | -27.25%15.69M | -53.94%18.44M | -42.37%20.91M |
| Prepaid assets | -91.29%1.22M | -72.19%4.03M | -72.19%4.03M | --7.23M | --11.63M | --14.02M | --14.49M | --14.49M | ---- | ---- |
| Other current assets | 64.49%7.92M | 27.23%7.32M | 27.23%7.32M | -71.82%6.21M | -69.96%7.33M | -81.04%4.81M | -82.49%5.75M | -82.49%5.75M | -25.59%22.04M | -42.09%24.4M |
| Total current assets | 80.43%203.78M | -3.65%113.83M | -3.65%113.83M | -8.65%100.12M | -5.36%112.1M | -6.44%112.94M | -36.20%118.15M | -36.20%118.15M | -53.85%109.6M | -61.06%118.45M |
| Non current assets | ||||||||||
| Net PPE | -38.50%9.02M | -35.07%10.42M | -35.07%10.42M | -32.14%11.83M | -29.53%13.26M | -55.26%14.66M | -53.32%16.05M | -53.32%16.05M | -51.51%17.44M | -49.88%18.81M |
| -Gross PPE | -38.50%9.02M | -35.07%10.42M | -35.07%10.42M | -32.14%11.83M | -29.53%13.26M | -55.26%14.66M | -53.32%16.05M | -53.32%16.05M | -51.51%17.44M | -49.88%18.81M |
| Goodwill and other intangible assets | -31.40%59.04M | -37.90%59.04M | -37.90%59.04M | -34.62%68.06M | -31.87%77.07M | -27.13%86.08M | -27.49%95.09M | -27.49%95.09M | -23.54%104.1M | -22.08%113.11M |
| -Goodwill | 0.00%59.04M | 0.00%59.04M | 0.00%59.04M | 0.00%59.04M | 0.00%59.04M | 7.25%59.04M | 0.00%59.04M | 0.00%59.04M | 7.25%59.04M | 7.25%59.04M |
| -Other intangible assets | ---- | ---- | ---- | -80.00%9.01M | -66.67%18.02M | -57.14%27.03M | -50.00%36.04M | -50.00%36.04M | -44.44%45.05M | -40.00%54.06M |
| Other non current assets | 225.12%38.34M | 200.87%37.38M | 200.87%37.38M | 602.59%27.13M | 431.03%17.78M | 125.14%11.79M | 131.25%12.42M | 131.25%12.42M | -85.30%3.86M | -90.42%3.35M |
| Total non current assets | -5.45%106.4M | -13.53%106.84M | -13.53%106.84M | -14.65%107.02M | -20.08%108.1M | -27.93%112.53M | -27.69%123.55M | -27.69%123.55M | -36.79%125.4M | -37.85%135.27M |
| Total assets | 37.57%310.19M | -8.70%220.67M | -8.70%220.67M | -11.85%207.14M | -13.21%220.2M | -18.56%225.48M | -32.12%241.7M | -32.12%241.7M | -46.09%235M | -51.38%253.71M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 6.53%12.66M | 3.72%15.18M | 3.72%15.18M | 49.30%13.49M | -14.17%10.11M | -5.53%11.88M | -18.79%14.64M | -18.79%14.64M | -54.14%9.04M | -52.79%11.78M |
| -accounts payable | 6.53%12.66M | 3.72%15.18M | 3.72%15.18M | 49.30%13.49M | -14.17%10.11M | -5.53%11.88M | -18.79%14.64M | -18.79%14.64M | -54.14%9.04M | -52.79%11.78M |
| Current accrued expenses | 21.33%24.43M | 8.78%24M | 8.78%24M | -0.82%17.66M | 49.03%18.87M | 6.86%20.13M | 19.24%22.07M | 19.24%22.07M | -69.23%17.81M | -79.13%12.66M |
| Current provisions | 80.52%32.64M | -25.87%21.02M | -25.87%21.02M | -30.96%18.74M | -31.72%19.07M | -19.17%18.08M | -16.73%28.36M | -16.73%28.36M | 7.63%27.15M | 6.72%27.93M |
| Current debt and capital lease obligation | 8.74%5.51M | -75.44%5.4M | -75.44%5.4M | -58.88%5.29M | -81.99%5.18M | -82.61%5.07M | -40.15%21.99M | -40.15%21.99M | -81.68%12.86M | -71.97%28.76M |
| -Current debt | ---- | ---- | ---- | ---- | ---- | ---- | -45.31%17.5M | -45.31%17.5M | -87.87%8M | -75.55%24M |
| -Current capital lease obligation | 8.74%5.51M | 20.24%5.4M | 20.24%5.4M | 8.80%5.29M | 8.87%5.18M | -1.72%5.07M | -5.33%4.49M | -5.33%4.49M | 14.11%4.86M | 7.58%4.76M |
| Current deferred liabilities | 78.56%1.24M | ---- | ---- | ---- | --43.3M | --695K | ---- | ---- | --0 | --0 |
| Other current liabilities | 88.67%9.08M | 32.86%6.11M | 32.86%6.11M | -47.61%2.96M | -1.45%4.41M | --4.81M | -30.02%4.6M | -30.02%4.6M | -58.75%5.64M | -68.58%4.48M |
| Current liabilities | 37.21%91.23M | -18.98%80.91M | -18.98%80.91M | -17.56%65.71M | 16.40%107.3M | -19.84%66.49M | -22.90%99.87M | -22.90%99.87M | -57.60%79.7M | -60.55%92.18M |
| Non current liabilities | ||||||||||
| Long term provisions | -13.79%34.42M | -5.19%38.01M | -5.19%38.01M | -0.35%40.2M | -1.49%40.02M | -2.13%39.93M | -2.19%40.09M | -2.19%40.09M | 50.61%40.35M | 55.92%40.62M |
| Long term debt and capital lease obligation | 28.73%48.63M | 61.65%42.24M | 61.65%42.24M | -3.45%43.29M | 47.93%44.33M | -29.66%37.78M | -58.55%26.13M | -58.55%26.13M | 46.14%44.84M | -5.57%29.97M |
| -Long term debt | 54.29%46.51M | 125.18%38.69M | 125.18%38.69M | 10.81%38.36M | 105.73%38.03M | 14.64%30.15M | -49.58%17.18M | -49.58%17.18M | --34.61M | --18.49M |
| -Long term capital lease obligation | -72.20%2.12M | -60.36%3.55M | -60.36%3.55M | -51.73%4.94M | -45.13%6.3M | -72.15%7.64M | -69.11%8.95M | -69.11%8.95M | -66.67%10.23M | -63.82%11.48M |
| Non current deferred liabilities | ---- | --0 | --0 | --0 | --0 | 0.00%43.3M | 0.00%43.3M | 0.00%43.3M | 0.00%43.3M | 0.00%43.3M |
| Derivative product liabilities | 45.13%7.22M | --5.18M | --5.18M | 360.66%3.5M | 247.89%2.64M | 554.61%4.98M | --0 | --0 | 0.00%760K | -31.53%760K |
| Other non current liabilities | 72.73%104.1M | 64.57%103.51M | 64.57%103.51M | 60.12%104.84M | -19.04%59.66M | -13.53%60.27M | -14.07%62.9M | -14.07%62.9M | -50.60%65.48M | -40.40%73.69M |
| Total non current liabilities | 4.36%194.38M | 9.58%188.94M | 9.58%188.94M | -1.48%191.84M | -22.13%146.65M | -10.57%186.25M | -22.08%172.42M | -22.08%172.42M | -16.81%194.72M | -16.60%188.34M |
| Total liabilities | 13.01%285.6M | -0.89%269.86M | -0.89%269.86M | -6.15%257.54M | -9.47%253.95M | -13.21%252.74M | -22.39%272.29M | -22.39%272.29M | -34.98%274.42M | -38.95%280.52M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K |
| -common stock | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K | 0.00%2K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -2.79%-1.67B | -4.31%-1.68B | -4.31%-1.68B | -2.86%-1.66B | -2.54%-1.64B | -3.03%-1.63B | -3.33%-1.61B | -3.33%-1.61B | -4.15%-1.61B | -6.80%-1.6B |
| Paid-in capital | 6.07%1.7B | 3.22%1.63B | 3.22%1.63B | 2.23%1.61B | 2.14%1.6B | 2.23%1.6B | 1.03%1.58B | 1.03%1.58B | 0.70%1.57B | 0.80%1.57B |
| Gains losses not affecting retained earnings | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K | 0.00%6K |
| Total stockholders'equity | 190.18%24.58M | -60.82%-49.19M | -60.82%-49.19M | -27.85%-50.4M | -25.91%-33.75M | -89.92%-27.26M | -684.78%-30.58M | -684.78%-30.58M | -384.57%-39.42M | -143.03%-26.81M |
| Total equity | 190.18%24.58M | -60.82%-49.19M | -60.82%-49.19M | -27.85%-50.4M | -25.91%-33.75M | -89.92%-27.26M | -684.78%-30.58M | -684.78%-30.58M | -384.57%-39.42M | -143.03%-26.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
